Delivery Order SPE2DB20D3103-SPE2DB25FP6E0
- Not listed
- The Defense Logistics Agency awarded a $4,476.10 delivery order to AmerisourceBergen Drug Corp for Kineret 100 mg/0.67 mL syringes on June 5, 2025, with an ultimate completion date of June 27, 2025. This firm fixed-price contract, which is non-set-aside and competitively awarded, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Kineret 100 mg/0.67 mL syringes with a ceiling value of $11,637.86 under a firm fixed price arrangement. This delivery order, which is a child contract under AmerisourceBergen's larger pharmaceutical supply agreement, will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. The award...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Kineret 100 mg/0.67 mL syringes. This firm fixed price delivery order, valued at approximately $14.3K, is scheduled for completion by September 16, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes with a ceiling value of $10,742.64 under a firm fixed-price arrangement. The order, issued on May 15, 2025, carries an ultimate completion date of June 6, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Kineret 100 mg/0.67 mL syringes, with a ceiling value of $11,637.86 and firm fixed pricing. This delivery order, which is not set-aside designated, represents a competitive award under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency (DLA) awarded a $7,161.76 delivery order to AmerisourceBergen Drug Corp for Kineret 100 mg/0.67 mL syringes on August 11, 2025, with an ultimate completion date of September 2, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a $3,580.88 delivery order to AmerisourceBergen Drug Corp for Kineret (anakinra) 100 mg/0.67 mL syringes on August 14, 2025, with a completion date of September 5, 2025. This firm fixed-price contract, which carries no set-aside designation, reflects a competitive award to the pharmaceutical distributor for delivery to its corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Kineret 100 mg/0.67 mL syringes, with a contract ceiling value of $7,161.76 and an ultimate completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,790.44 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes. This competitive, non-set-aside contract utilizes firm fixed pricing and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of May 30, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Kineret 100 mg/0.67 mL syringes. This competitively awarded, firm fixed-price contract carries a ceiling value of $7,161.76 with an ultimate completion date of May 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order. The contract is a child order under AmerisourceBergen's larger...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6E0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,323.52 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes on July 23, 2025, with completion expected by August 13, 2025. This is a firm fixed-price delivery order issued under a competitively awarded indefinite delivery contract. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award reflects no set-aside designation, indicating it was awarded through open competition. This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp leverages this comprehensive global contract vehicle to supply pharmaceutical products and medical supplies supporting military healthcare programs worldwide. The Kineret delivery represents the company's continued role as a critical vendor for federal medical procurement, serving the Defense Health Agency and other government healthcare systems with specialty medications and injectable therapeutics across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 7/23/25 |